Transpek Industry Limited · BSE:TRANSPEK
Transpek Industry — Investor Presentation (September 2020)
39 slides from Transpek Industry's investor presentation, September 2020
Slide 1: Transpek Industry Limited Investor Presentation September 2020
Transpek Industry Limited Investor Presentation September 2020
Slide 2: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Transpek Industry Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se
Slide 3: Transpek at Glance
Transpek at Glance
Slide 4: About us
About us Environment Protection Founded by Shri. Govindji Shroff in 1965 Over 5 decades Creative Over three Part of Excel experience in Chemistry decades of presence in the group of Sulphur and international companies Chlorine market Chemistry Customer Exploring every Headquartered Focus possible in
Slide 5: Our journey over five decades
Our journey over five decades 2017 Long term supply agreement with global chemical giant 2018 Started supplying under long 2004 term supply agreement and Set up of First Multi Purpose became big global player in acid Acid Chloride Plant chlorides 2012 1987 Significant strategic shift from Started ma
Slide 6: Our products are supplied to varied industries
Our products are supplied to varied industries Q1 FY21 Sales Distribution based on Application Leading global supplier for ‘Chlorinated Products’ to various industry sectors ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. 4.0% 6.2% Polymers Pharma Specialty Chemicals 18.3% 71.5% Ag
Slide 7: Our products have multiple applications
Our products have multiple applications Diversified Products Across India’s Fastest Growing Industries • 2, 4, 6 Trimethyl Benzoyl • 2-Methoxyethyl chloride • 2-Chloroethylamine • 2-Chloroethylamine Chloride • Cocoyl Chloride • 2-Propoxyethyl chloride Hydrochloride Solution Hydrochloride Solution •
Slide 8: Our capabilities developed over years
Our capabilities developed over years Research & Development Sustainability Ratings ◊ In house development of products ◊ ECOVADIS Sustainability platform – the company is ◊ DSIR approved R&D Facility rated very high with ‘Silver Badge’ ◊ R&D Lab approved by MS University of Baroda for ◊ One of those
Slide 9: Our clients trust in our capabilities & chemistries
Our clients trust in our capabilities & chemistries Company has built an excellent reputation globally – Testament to our Reliability and Trustworthiness Long-term supply agreement commenced from 1st January 2018 Contract 10 years Period Exclusive contract with a High performance product with dedica
Slide 10: Our plants are multipurpose and multiproduct
Our plants are multipurpose and multiproduct Ekalbara Located ~25 km away from the headquarter location at Vadodara, Gujarat. Dedicated multipurpose and multiproduct plants spread over 100 acres with total production capacity of • Strategically located in largest chemical 66,000 MT/P.A. manufacturin
Slide 11: Our R & D facility is recognized by Government of India
Our R & D facility is recognized by Government of India Research & Development Developed a comprehensive in-house R&D facility recognized by the Department of Science & Technology, Government of India, which is equipped with latest technology and equipment Every new and existing product undergoes a
Slide 12: Our top management is committed to process safety
Our top management is committed to process safety PHA Chemical Release • Process Hazard Analysis 01 • Dispersion Modeling Studies conducted for all products and • Storage Quantity Reduction processes 02 • Mechanical Integrity of Equipment Top Management 06 PSSR • Total commitment and • Pre-Startup s
Slide 13: Our transportation is safe, systematic and sustainable
Our transportation is safe, systematic and sustainable Logistics Safe, systematic and sustainable transportation is a key challenge to ever changing global chemical industry Pioneers in developing in-house ISO Tank station which is well equipped with state-of-the-art technology We manage over 600 IS
Slide 14: Our products are delivered across the globe
Our products are delivered across the globe One of the Pioneering Global Exporters from India since 1986 FY20 - Revenue Breakup Long term relations with Leading Global Chemical Giants 17% Sweden 83% Spain Germany Russia France Italy Switzerland Domestic International U.S.A. Japan China South Korea T
Slide 15: Our board has vast industry experience
Our board has vast industry experience Mr. Ashwin C. Shroff | Chairman Mr. Bernd Dill | Independent Director He is a science graduate, Mr. Shroff have emerged stronger, helping the growth of He is a German national, having emphasis on mathematics and natural sciences, Doctoral Industrial chemicals,
Slide 16: Our company has adopted a sustainable method of doing business
Our company has adopted a sustainable method of doing business Community Empowerment Biodiversity Serving the society in various areas Maintaining and enhancing green belt (flora and like health & hygiene, education, skill fauna) within the factory premises through development, vocational training e
Slide 17: ESG at the heart of all we do
ESG at the heart of all we do
Slide 18: Corporate social responsibility
Corporate social responsibility Women Empowerment Workshops Vocational Training Understanding the needs of communities, addressing them Our vision is to actively contribute towards through need-based projects and making them work together creating innovative and sustainable solutions in to help crea
Slide 19: Awards and Recognitions – A glimpse
Awards and Recognitions – A glimpse Government of Gujarat: FGI Award for Excellence in the field of Indian Chemical Council: Excellence in CSR Award Environment Pollution Abatement & Best in Social Responsibility Award Preservation Shri Atul Shroff MD & Union Leader Shri Ashok Shri Bimal V. Mehta, E
Slide 20: Environment, health and safety
Environment, health and safety Rainwater harvesting and recharging Green cover in Transpek premise Safety is our responsibility We have Full-fledged Effluent management system with a licensed discharge facility to the central Effluent channel Our company has 100 acres of land with a green belt of mo
Slide 21: Socially responsible at the time of COVID – 19
Socially responsible at the time of COVID – 19 Activities done during COVID-19: Arranged for immunity boosting medicines including multi vitamins, zinc and iron sucrose injections, as per the requirements of Primary Health Centre – Mujpur, along with gloves and sanitizer bottles for their health sta
Slide 22: Way Forward
Way Forward
Slide 23: Growth Initiatives
Growth Initiatives Focus on Value-Added Products Growing opportunities in Pharma and Agro 01 One key focus area of the company is to introduce products that are intermediates (all current products are starting RMs) 04 We have identified few intermediates on which work is going on. Currently the prod
Slide 24: Business Update
Business Update o We are relentlessly working towards mitigating the concentration risk by adding new customers and geographies Concentration o In addition to this, the company is also working to add more products and chemistries o Risk arising due to foreign exchange fluctuation is largely mitigate
Slide 25: Q1 FY21 - Financial Highlights
Q1 FY21 - Financial Highlights
Slide 26: Q1 FY21 – Consolidated Profit & Loss Account
Q1 FY21 – Consolidated Profit & Loss Account Particulars (Rs. Crores) Q1 FY21 Q1 FY20 Y-o-Y Q4 FY20 Q-o-Q Revenue from Operations 74.7 112.6 161.8 Other Income 4.9 5.7 4.0 Total Revenue from operations 79.6 118.3 -33% 165.9 -52% Cost of materials consumed 32.7 54.3 59.8 Purchases of stock-in-trade 0
Slide 27: Q1 FY21 – Consolidated Financial Highlights
Q1 FY21 – Consolidated Financial Highlights Revenue* (Rs. In Cr) EBITDA* (Rs. In Cr) Profit after Tax (Rs. In Cr) -3% +13% -33% 118.3 14.3 13.8 3.8 3.3 79.6 Q1 FY20 Q1 FY21 Q1 FY20 Q1 FY21 Q1 FY20 Q1 FY21 EBITDA Margins (%) PAT Margins (%) +580 bps +210 bps 18.5% 5.1% 12.7% 3.0% Q1 FY20 Q1 FY21 Q1 F
Slide 28: FY20 - Financial Highlights
FY20 - Financial Highlights
Slide 29: FY20 - Consolidated Profit & Loss Account
FY20 - Consolidated Profit & Loss Account Particulars (Rs. Crores) FY20 FY19 Y-o-Y Revenue from Operations 565.6 594.6 Other Income 17.4 17.8 Total Revenue from operations 583.0 612.4 -5% Cost of materials consumed 253.1 304.3 Purchases of stock-in-trade 0.0 0.1 Changes in inventories of finished go
Slide 30: FY20 - Consolidated Balance Sheet
FY20 - Consolidated Balance Sheet Liabilities Mar-20 Mar-19 Assets Mar-20 Mar-19 Equity Non Current assets Property, Plant and Equipment 270.7 236.5 Equity Share capital 5.6 5.6 Capital work-in-progress 18.6 32.8 Other Equity 332.9 305.8 Right to use of lease assets 16.0 0.0 Total Equity 338.5 311.4
Slide 31: FY20 - Consolidated Cash Flows Statement
FY20 - Consolidated Cash Flows Statement Particulars (Rs. Crores) Mar-20 Mar-19 Net Profit Before Tax 93.5 101.3 Adjustments for: Non-Cash Items / Other Investment or Financial Items 39.3 29.9 Operating profit before working capital changes 132.8 131.3 Changes in working capital 2.0 16.0 Cash genera
Slide 32: FY20 – Consolidated Financial Highlights
FY20 – Consolidated Financial Highlights Revenue* (Rs. In Cr) EBITDA* (Rs. In Cr) Profit after Tax (Rs. In Cr) -5% +1% +11% 612.4 583.0 134.4 135.3 73.0 65.7 FY19 FY21 FY19 FY20 FY19 FY20 EBITDA Margins (%) PAT Margins (%) +130 bps +180 bps 22.6% 23.9% 12.9% 11.1% FY19 FY20 FY19 FY20 32 *Includes ot
Slide 33: Historical Financial Highlights
Historical Financial Highlights
Slide 34: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account Particulars (Rs. Crores) FY20 FY19 FY18 FY17 Revenue from Operations* 565.6 594.6 361.2 316.6 Other Income 17.4 17.8 9.8 7.4 Total Revenue 583.0 612.4 370.9 324.0 Cost of materials consumed 253.1 304.3 186.8 139.1 Purchases of stock-in-trade 0.0 0.1 8.0 6.7 Changes
Slide 35: Consolidated Balance Sheet - Assets
Consolidated Balance Sheet - Assets Assets Mar-20 Mar-19 Mar-18 Mar-17 Non Current assets Property, Plant and Equipment 270.7 236.5 178.6 117.1 Capital work-in-progress 18.6 32.8 56.4 13.0 Right to use of lease assets 16.0 0.0 0.0 0.0 Investment In subsidiary 0.0 0.0 0.0 0.0 Financial Assets (i) Inv
Slide 36: Consolidated Balance Sheet - Liabilities
Consolidated Balance Sheet - Liabilities Liabilities Mar-20 Mar-19 Mar-18 Mar-17 Equity Equity Share capital 5.6 5.6 5.6 5.6 Other Equity 332.9 305.8 241.4 200.0 Total Equity 338.5 311.4 246.9 205.6 Financial liabilities (i) Borrowings 44.6 68.8 85.4 25.0 (ii) Other Financial liabilities 9.6 0.0 0.0
Slide 37: Consolidated Financial Highlights
Consolidated Financial Highlights Revenue* (Rs. In Cr) EBITDA* (Rs. In Cr) & EBITDA Margin (%) PAT (Rs. In Cr) & PAT Margin (%) 35 134.4 135.3 140 14 12.9% 100 +22% 11.1% 30 12 22.6% 23.9% 120 9.5% 612.4 25 10 73.0 80 583.0 19.0% 100 7.3% 65.7 20 15.7% 8 370.9 60 324.0 15 80 6 10 60.2 4 40 56.9 60 3
Slide 38: Consistent Dividend Performance
Consistent Dividend Performance Dividend Dividend Per Share 20.0 220 20 200% 200 18 180 16 160 14 140 125% 120 12 12.5 100 90% 90% 10 80 75% 9.0 9.0 8 60 50% 7.5 6 40 25% 5.0 4 20 2.5 0 2 FY14 FY15 FY16 FY17 FY18 FY19 FY20 38
Slide 39: Thank You
Contact Information Company : Investor Relations Advisor : Transpek Industry Limited Strategic Growth Advisors Pvt. Ltd. CIN: L23205GJ1965PLC001343 CIN: U74140MH2010PTC204285 Mr. Alak D. Vyas Ms. Neha Shroff / Mr. Abhishek Shah E: neha.shroff@sgapl.net / abhishek.shah@sgapl.net E: secretarial@transp
Transpek Industry — Investor Presentation (September 2020) on 6ix